Literature DB >> 25708191

Pre-B cell receptor binding to galectin-1 modifies galectin-1/carbohydrate affinity to modulate specific galectin-1/glycan lattice interactions.

Jeremy Bonzi1, Olivier Bornet2, Stephane Betzi3, Brian T Kasper4, Lara K Mahal4, Stephane J Mancini5, Claudine Schiff5, Corinne Sebban-Kreuzer1, Francoise Guerlesquin1, Latifa Elantak1.   

Abstract

Galectins are glycan-binding proteins involved in various biological processes including cell/cell interactions. During B-cell development, bone marrow stromal cells secreting galectin-1 (GAL1) constitute a specific niche for pre-BII cells. Besides binding glycans, GAL1 is also a pre-B cell receptor (pre-BCR) ligand that induces receptor clustering, the first checkpoint of B-cell differentiation. The GAL1/pre-BCR interaction is the first example of a GAL1/unglycosylated protein interaction in the extracellular compartment. Here we show that GAL1/pre-BCR interaction modifies GAL1/glycan affinity and particularly inhibits binding to LacNAc containing epitopes. GAL1/pre-BCR interaction induces local conformational changes in the GAL1 carbohydrate-binding site generating a reduction in GAL1/glycan affinity. This fine tuning of GAL1/glycan interactions may be a strategic mechanism for allowing pre-BCR clustering and pre-BII cells departure from their niche. Altogether, our data suggest a novel mechanism for a cell to modify the equilibrium of the GAL1/glycan lattice involving GAL1/unglycosylated protein interactions.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25708191     DOI: 10.1038/ncomms7194

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  17 in total

1.  N-Glycan Branching Is Required for Development of Mature B Cells.

Authors:  Christie-Lynn Mortales; Sung-Uk Lee; Michael Demetriou
Journal:  J Immunol       Date:  2020-06-26       Impact factor: 5.422

Review 2.  Breaking the Glyco-Code of HIV Persistence and Immunopathogenesis.

Authors:  Florent Colomb; Leila B Giron; Irena Trbojevic-Akmacic; Gordan Lauc; Mohamed Abdel-Mohsen
Journal:  Curr HIV/AIDS Rep       Date:  2019-04       Impact factor: 5.071

3.  Dynamic pre-BCR homodimers fine-tune autonomous survival signals in B cell precursor acute lymphoblastic leukemia.

Authors:  M Frank Erasmus; Ksenia Matlawska-Wasowska; Ichiko Kinjyo; Avanika Mahajan; Stuart S Winter; Li Xu; Michael Horowitz; Diane S Lidke; Bridget S Wilson
Journal:  Sci Signal       Date:  2016-11-29       Impact factor: 8.192

Review 4.  Extracellular galectins as controllers of cytokines in hematological cancer.

Authors:  Monica Gordon-Alonso; Annika M Bruger; Pierre van der Bruggen
Journal:  Blood       Date:  2018-06-06       Impact factor: 22.113

Review 5.  A new therapeutic target: the CD69-Myl9 system in immune responses.

Authors:  Motoko Y Kimura; Ryo Koyama-Nasu; Ryoji Yagi; Toshinori Nakayama
Journal:  Semin Immunopathol       Date:  2019-04-05       Impact factor: 9.623

6.  Exploring the In situ pairing of human galectins toward synthetic O-mannosylated core M1 glycopeptides of α-dystroglycan.

Authors:  Lareno L Villones; Anna-Kristin Ludwig; Hiroyuki Kumeta; Seiya Kikuchi; Rika Ochi; Tomoyasu Aizawa; Shin-Ichiro Nishimura; Hans-Joachim Gabius; Hiroshi Hinou
Journal:  Sci Rep       Date:  2022-10-23       Impact factor: 4.996

7.  Structural Basis Underlying the Binding Preference of Human Galectins-1, -3 and -7 for Galβ1-3/4GlcNAc.

Authors:  Tung-Ju Hsieh; Hsien-Ya Lin; Zhijay Tu; Bo-Shun Huang; Shang-Chuen Wu; Chun-Hung Lin
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

8.  Galectin-1 is required for the regulatory function of B cells.

Authors:  R Alhabbab; P Blair; L A Smyth; K Ratnasothy; Q Peng; A Moreau; R Lechler; R Elgueta; G Lombardi
Journal:  Sci Rep       Date:  2018-02-09       Impact factor: 4.379

9.  Treatment of B-cell precursor acute lymphoblastic leukemia with the Galectin-1 inhibitor PTX008.

Authors:  Helicia Paz; Eun Ji Joo; Chih-Hsing Chou; Fei Fei; Kevin H Mayo; Hisham Abdel-Azim; Haike Ghazarian; John Groffen; Nora Heisterkamp
Journal:  J Exp Clin Cancer Res       Date:  2018-03-27

10.  Galectins in Intestinal Inflammation: Galectin-1 Expression Delineates Response to Treatment in Celiac Disease Patients.

Authors:  Victoria Sundblad; Amado A Quintar; Luciano G Morosi; Sonia I Niveloni; Ana Cabanne; Edgardo Smecuol; Eduardo Mauriño; Karina V Mariño; Julio C Bai; Cristina A Maldonado; Gabriel A Rabinovich
Journal:  Front Immunol       Date:  2018-03-01       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.